Bruker (BRKR) EBT (2010 - 2026)

Bruker (BRKR) has reported EBT for 17 consecutive years, with -$51.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 950.0% year-over-year to -$51.0 million; the trailing twelve-month figure through Jun 2026 stood at $278.7 million (down 27.55% YoY), and the FY2025 full-year result was $339.9 million, down 25.64% from the prior year.
• EBT declined to -$51.0 million in Q2 2026 per BRKR's latest filing, from $15.4 million in the prior quarter.
• Across five years, EBT topped out at $386.1 million in Q4 2025 and bottomed at -$71.8 million in Q3 2025.
• Historically, EBT has averaged $81.9 million across 5 years, with a median of $56.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: EBT soared 207.44% in 2022, then sank 950.0% in 2026.
• Over 5 years, EBT stood at $134.3 million in 2022, then surged by 79.37% to $240.9 million in 2023, then increased by 27.15% to $306.3 million in 2024, then rose by 26.05% to $386.1 million in 2025, then slumped by 113.21% to -$51.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$51.0 million, $15.4 million, and $386.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.